...
首页> 外文期刊>Vaccine >A prime-boost immunisation regimen using recombinant BCG and Pr55gag virus-like particle vaccines based on HIV type 1 subtype C successfully elicits Gag-specific responses in baboons.
【24h】

A prime-boost immunisation regimen using recombinant BCG and Pr55gag virus-like particle vaccines based on HIV type 1 subtype C successfully elicits Gag-specific responses in baboons.

机译:使用重组BCG和基于C型HIV 1亚型的Pr55 gag 病毒样颗粒疫苗的初免-加强免疫方案成功地在狒狒中引发了Gag特异性反应。

获取原文
获取原文并翻译 | 示例
           

摘要

Mycobacterium bovis BCG is considered an attractive live bacterial vaccine vector. In this study, we investigated the immune response of baboons to a primary vaccination with recombinant BCG (rBCG) constructs expressing the gag gene from a South African HIV-1 subtype C isolate, and a boost with HIV-1 subtype C Pr55gag virus-like particles (Gag VLPs). Using an interferon enzyme-linked immunospot assay, we show that although these rBCG induced only a weak or an undetectable HIV-1 Gag-specific response on their own, they efficiently primed for a Gag VLP boost, which strengthened and broadened the immune responses. These responses were predominantly CD8+ T cell-mediated and recognised similar epitopes as those targeted by humans with early HIV-1 subtype C infection. In addition, a Gag-specific humoral response was elicited. These data support the development of HIV-1 vaccines based on rBCG and Pr55gag VLPs.
机译:牛分枝杆菌 BCG被认为是一种有吸引力的活细菌疫苗载体。在这项研究中,我们调查了狒狒对表达来自南非HIV-1亚型C分离株的 gag 基因的重组BCG(rBCG)初次接种疫苗的免疫反应,并通过HIV- 1个亚型C Pr55 gag 病毒样颗粒(Gag VLP)。使用干扰素酶联免疫斑点测定法,我们显示,尽管这些rBCG自身仅诱导了微弱或无法检测到的HIV-1 Gag特异性反应,但它们有效地引发了Gag VLP增强反应,从而增强并扩大了免疫反应。这些反应主要是CD8 + T细胞介导的,并识别出与早期HIV-1 C型亚型感染人群所靶向的相似表位。另外,引起了Gag特异性的体液反应。这些数据支持基于rBCG和Pr55 gag VLP的HIV-1疫苗的开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号